共 126 条
- [1] Vrints C., Andreotti F., Koskinas K.C., Rossello X., Adamo M., Ainslie J., Banning A.P., Budaj A., Buechel R.R., Chiariello G.A., Et al., ESC 2024 Guidelines for the management of chronic coronary syndromes, Eur. Heart J, 45, pp. 3415-3537, (2024)
- [2] Jebari-Benslaiman S., Galicia-Garcia U., Larrea-Sebal A., Olaetxea J.R., Alloza I., Vandenbroeck K., Benito-Vicente A., Martin C., Pathophysiology of Atherosclerosis, Int. J. Mol. Sci, 23, (2022)
- [3] Scarsini R., Fezzi S., Leone A.M., De Maria G.L., Pighi M., Marcoli M., Tavella D., Pesarini G., Banning A.P., Barbato E., Et al., Functional patterns of coronary disease: Diffuse, focal, and serial lesions, JACC Cardiovasc. Interv, 15, pp. 2174-2191, (2022)
- [4] Maron D.J., Hochman J.S., Reynolds H.R., Bangalore S., O'Brien S.M., Boden W.E., Chaitman B.R., Senior R., Lopez-Sendon J., Alexander K.P., Et al., Initial invasive or conservative strategy for stable coronary disease, N. Engl. J. Med, 382, pp. 1395-1407, (2020)
- [5] Hochman J.S., Anthopolos R., Reynolds H.R., Bangalore S., Xu Y., O'Brien S.M., Mavromichalis S., Chang M., Contreras A., Rosenberg Y., Et al., Survival after invasive or conservative management of stable coronary disease, Circulation, 147, pp. 8-19, (2023)
- [6] Lopes R.D., Alexander K.P., Stevens S.R., Reynolds H.R., Stone G.W., Pina I.L., Rockhold F.W., Elghamaz A., Lopez-Sendon J.L., Farsky P.S., Et al., Initial invasive versus conservative management of stable ischemic heart disease in patients with a history of heart failure or left ventricular dysfunction, Circulation, 142, pp. 1725-1735, (2020)
- [7] Fearon W.F., Zimmermann F.M., De Bruyne B., Piroth Z., van Straten A.H.M., Szekely L., Davidavicius G., Kalinauskas G., Mansour S., Kharbanda R., Et al., Fractional flow reserve-guided PCI as compared with coronary bypass surgery, N. Engl. J. Med, 386, pp. 128-137, (2022)
- [8] Sabatine M.S., Bergmark B.A., Murphy S.A., O'Gara P.T., Smith P.K., Serruys W., Kappetein A.P., Park S.J., Park D.W., Christiansen E.H., Et al., Percutaneous coronary intervention with drug-eluting stents versus coronary artery bypass grafting in left main coronary artery disease: An individual patient data meta-analysis, Lancet, 398, pp. 2247-2257, (2021)
- [9] Rozanski A., Miller R.J.H., Gransar H., Han D., Slomka P., Dey D., Hayes S.W., Friedman J.D., Thomson L., Berman D.S., Benefit of early revascularization based on inducible ischemia and left ventricular ejection fraction, J. Am. Coll. Cardiol, 80, pp. 202-215, (2022)
- [10] Reynolds H.R., Shaw L.J., Min J.K., Page C.B., Berman D.S., Chaitman B.R., Picard M.H., Kwong R.Y., O'Brien S.M., Huang S., Et al., Outcomes in the ISCHEMIA trial based on coronary artery disease and ischemia severity, Circulation, 144, pp. 1024-1038, (2021)